RPG LifeScience.

41
Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE105J01010
  • NSEID: RPGLIFE
  • BSEID: 532983
INR
1,962.30
-139.9 (-6.65%)
BSENSE

Jan 28

BSE+NSE Vol: 1.97 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
RPG LifeScience. Cash flow Statement
Figures in Cr
Consolidated Cash Flow Results
Mar'07
No of Months
12
Profit Before Tax
9.94
Adjustment
15.00
Changes In working Capital
-9.38
Cash Flow after changes in Working Capital
15.56
Cash Flow from Operating Activities
15.32
Cash Flow from Investing Activities
-6.21
Cash Flow from Financing Activities
-28.21
Net Cash Inflow / Outflow
-19.10
Opening Cash & Cash Equivalents
27.10
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
Effect of Foreign Exchange Fluctuations
0.00
Closing Cash & Cash Equivalent
8.00
Figures in INR Cr
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of RPG LifeScience.
Markets Mojo
Figures in Cr
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Profit Before Tax
99408
70.57
99,338.00
140764.39%
Adjustment
149994
27.11
1,49,967.00
553179.23%
Changes In working Capital
-93845
-134.43
-93,711.00
-69709.57%
Cash Flow after changes in Working Capital
155557
-36.75
1,55,593.00
423384.35%
Cash Flow from Operating Activities
153192
-45.92
1,53,237.00
333706.27%
Cash Flow from Investing Activities
-62108
-429.48
-61,679.00
-14361.21%
Cash Flow from Financing Activities
-282078
573.13
-2,82,651.00
-49317.11%
Net Cash Inflow / Outflow
-190994
97.73
-1,91,091.00
-195530.27%
Opening Cash & Cash Equivalents
271005
7.65
2,70,998.00
3542449.02%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
80011
105.38
79,906.00
75826.17%
Cash Flow - Snapshot (Standalone) - Mar'25
stock-summary

YoY Growth in year ended Mar 2025 is -17.49% vs 3.90% in Mar 2024

Mar'25
Mar'24
Change(%)
Cash Flow from Operating Activities
77.86
94.36
-17.49%